(Q40632605)

English

Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma

scientific article published on August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma (English)

1 reference

Europe PubMed Central

22 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Muñoz L

1

1 reference

Europe PubMed Central

22 September 2017

Martino R

2

1 reference

Europe PubMed Central

22 September 2017

Subirà M

3

1 reference

Europe PubMed Central

22 September 2017

Brunet S

4

1 reference

Europe PubMed Central

22 September 2017

Sureda A

5

1 reference

Europe PubMed Central

22 September 2017

Sierra J

6

1 reference

Europe PubMed Central

22 September 2017

publication date

1 August 1999

1 reference

Europe PubMed Central

22 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

22 September 2017

34

1 reference

Europe PubMed Central

22 September 2017

585-589

1 reference

Europe PubMed Central

22 September 2017

5-6

1 reference

Europe PubMed Central

22 September 2017

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 microg/m2) after salvage chemotherapy for lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Management of infections during intensive treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.3109%2F10428199909058487

21 January 2018

Identifiers

10.3109/10428199909058487

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40632605&oldid=1903813943"